Lifecycle Management Strategies: Maximizing ROI through indication expansion, reformulation and Rx-to-OTC switching

Abstract

With declining R&D productivity and maturing product portfolios, maximizing revenues through lifecycle management has never been more important for pharmaceutical companies. Upon patent expiry, companies risk losing up to 80% of brand sales, highlighting the importance of implementing successful strategies for brand protection and market expansion. Maximize revenue at all stages of the product lifecycle and minimize the impact of generic competition on your brand with the help of this new management report. 'Lifecycle Management Strategies' is a new management report which provides practical solutions to tackle the loss of market share to generic competition at patent expiry. Strategies including Rx-to-OTC switching, indication expansion and reformulation are evaluated in terms of product and developer characteristics, economic viability and regulatory compliance. This will ensure that you are able to select a strategy that will maximize return on investment and sustain brand loyalty.